Blood pressure management is crucial in diabetes to prevent vascular complications. Renin-angiotensin system (RAS) blockers (angiotensin converting enzyme inhibitors, angiotensin receptor blockers) are preferred drugs in all guidelines. To determine frequency of RAS blocker use in patients with type 2 diabetes and hypertension we performed a multisite study in India.Design and Method:
We evaluated physician prescriptions in consecutive patients with type-2 diabetes presenting to clinics at 9 sites in India. Details of sociodemographic characteristics, clinical findings and prescription medicines were obtained. Descriptive statistics are reported.Results:
We obtained treatment details in 8699 diabetic patients (5292 men, 3407 women). Hypertension was reported in 3625 (41.7%), no hypertension in 3975 (45.7%) and overt coronary heart disease with or without hypertension in 1099 (12.6%). Use of various classes of anti-hypertensive drugs was RAS blockers in 2566 (29.5%), beta-blockers 1268 (14.6%), calcium channel blockers 952 (10.9%), diuretics 1168 (13.4%) and statins 4280 (49.2%), Use of these drugs in the three groups is shown in Table.Conclusions:
Use of vasculoprotective RAS blockers and statins in uncomplicated as well as complicated hypertensive patients with type 2 diabetes mellitus in India is low.